ZEB2 and breast carcinoma: Results of recent studies have shown that ZEB1 and ZEB2 are associate with the response to radiotherapy and chemotherapy of several cancers, such as pancreatic carcinoma, head and neck squamous carcinoma, squamous carcinoma, breast cancer, non-small cell lung, and bladder carcinoma [42].